Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy

Author: Coughlin Christina   Johnston Daniel   Strahs Andrew   Burczynski Michael   Bacus Sarah   Hill Jason   Feingold Jay   Zacharchuk Charles   Berkenblit Anna  

Publisher: Springer Publishing Company

ISSN: 0167-6806

Source: Breast Cancer Research and Treatment, Vol.124, Iss.1, 2010-11, pp. : 1-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content